预防和治疗骨质疏松临床医师指南+2013+NOF.pdf

CHAPTE R 1 ■ O STEOP OROSIS: WHA T IT IS AND WHO IS AT RISK5 Clinician’s Guide National Osteoporosis Foun dation Bone Source Knowledge. Competence. Results. Developed by the National Osteoporosis Foundation to Prevention and Treatment of Osteoporosis 2013 Issue, Version 3 Released February 25, 2014 © National Osteoporosis Foundation (NOF). All rights reserved. guide.medlive.cn 2013 CLINICIAN’S GUIDE TO PREVENTION AND TREATMENT OF OSTEOPOROSIS 1 2013 Issue, Version 3 Released February 25, 2014 The 2013 issue of NOF's Clinician's Guide contains updated guidance on vertebral fracture assessment and the use of biochemical markers of bone turnover, as well as updated information on calcium, vitamin D and medications. The 2013 issue was first released on March 1, 2013. The Guide was revised following the FDA’s review on calcitonin and version two was released April 2013. Additional edits were made to ensure consistency with the International Socie ty of Clinical Densitometry (ISCD) Official Positions announced in November 2013 and version three was released on February 25, 2014. This Guide was developed by an expert committee of the National Osteoporosis Foundation (NOF) in collaboration with a multi -specialty council of medical experts in the field of bone health convened by NOF. Readers are urged to consult current prescribing information on any drug, device or procedure discussed in this publication. Attention Clinicians: It is important to note that the recommendations developed in this Guide are intended to serve as a reference point for clinical decision-making with individual patients. They are not intended to be rigid standards, limits or rules and can be tailored to individual cases to inco rporate personal facts that are beyond the scope of this Guide. Because these are recommendations and not rigid standards, they should not be interpreted as quality standards. Nor should they be used to limit coverage for tre